Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

EPSILON : revenue, balance sheet and financial ratios

EPSILON is a French company founded 11 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in CAVAILLON (84300), this company of category PME shows in 2017 a net income positive of 327 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - EPSILON (SIREN 810043547)
Indicator 2017 2016 2015
Revenue N/C N/C N/C
Net income 326 679 € 20 923 € -2 572 €
EBITDA N/C N/C -1 057 €
Net margin N/C N/C N/C

Revenue and income statement

In 2017, EPSILON generates positive net income of 327 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2017) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

326 679 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 71%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 19%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2017) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

71.449%

Financial autonomy (2017) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

18.698%

Asset age ratio (2017) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

55.1%

Solvency indicators evolution
EPSILON

Sector positioning

Debt ratio
71.45 2017
2015
2016
2017
Q1: 0.0
Med: 6.83
Q3: 49.59
Watch +23 pts over 3 years

In 2017, the debt ratio of EPSILON (71.45) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
18.7% 2017
2015
2016
2017
Q1: 14.21%
Med: 37.04%
Q3: 60.18%
Average -31 pts over 3 years

In 2017, the financial autonomy of EPSILON (18.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
-0.35 years 2015
2015
Q1: -0.01 years
Med: 0.0 years
Q3: 0.28 years
Excellent

In 2015, the repayment capacity of EPSILON (-0.35) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 145.69. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2017) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

145.686

Liquidity indicators evolution
EPSILON

Sector positioning

Liquidity ratio
145.69 2017
2015
2016
2017
Q1: 131.18
Med: 189.43
Q3: 305.54
Average +9 pts over 3 years

In 2017, the liquidity ratio of EPSILON (145.69) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
0.0x 2015
2015
Q1: 0.0x
Med: 0.0x
Q3: 2.63x
Average

In 2015, the interest coverage of EPSILON (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Positioning of EPSILON in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of EPSILON is estimated at 268 371 € (range 102 144€ - 980 060€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2017
124 transactions
102k€ 268k€ 980k€
268 371 € Range: 102 144€ - 980 060€
NAF 5 all-time

Valuation method used

Net Income Multiple
326 679 € × 0.8x = 268 372 €
Range: 102 144€ - 980 060€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare EPSILON with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about EPSILON

What is the revenue of EPSILON ?

The revenue of EPSILON is not publicly disclosed (confidential accounts filed with INPI).

Is EPSILON profitable?

Yes, EPSILON generated a net profit of 327 k€ in 2017.

Where is the headquarters of EPSILON ?

The headquarters of EPSILON is located in CAVAILLON (84300), in the department Vaucluse.

Where to find the tax return of EPSILON ?

The tax return of EPSILON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does EPSILON operate?

EPSILON operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.